Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
S0VHduhCnT06uXSq
